Migraine Trials in Philadelphia, United States
Conditions / Migraine / Philadelphia, United States
Research into Migraine spans multiple therapeutic approaches and trial phases.
66 total trials for this combination
Showing top 10 of 66 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03836040 | Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04041284 | A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder | COMPLETED | PHASE4 |
| NCT02629861 | Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine | COMPLETED | PHASE3 |
| NCT04804033 | A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention | TERMINATED | PHASE2/PHASE3 |
| NCT04571060 | Randomized Trial in Adult Participants With Acute Migraines | COMPLETED | PHASE3 |
| NCT03832998 | Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine | COMPLETED | PHASE3 |
| NCT03896009 | Maximizing Outcomes in Treating Acute Migraine | COMPLETED | PHASE3 |
| NCT02614196 | Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study | COMPLETED | PHASE3 |
| NCT02638103 | Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine | COMPLETED | PHASE3 |
| NCT02621931 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine | COMPLETED | PHASE3 |